Results 201 to 210 of about 214,511 (232)
Some of the next articles are maybe not open access.
Fluconazole for antifungal prophylaxis in chemotherapy-induced neutropenia
American Journal of Health-System Pharmacy, 1995Fluconazole is compared with other agents for antifungal prophylaxis in patients with chemotherapy-induced neutropenia. Fluconazole is an attractive alternative for antifungal prophylaxis because of its activity against many Candida species, long half-life, good patient tolerability, and minimal associated toxicity.
S L, Preston, L L, Briceland
openaire +2 more sources
Antifungal prophylaxis for the prevention of neonatal candidiasis?
Acta Paediatrica, 2008AbstractBackground: Randomized controlled trials suggest that prophylactic administration of antifungal agents reduce the rate of colonization and invasive Candida infection in a subgroup of high‐risk very low birth weight (VLBW) neonates. The extent of antifungal prophylaxis use in the United Kingdom and Ireland is unknown.Methods: A postal ...
Michael J, O'Grady, Eugene M, Dempsey
openaire +2 more sources
[Antifungal prophylaxis in neutropenic patients].
Wiener medizinische Wochenschrift (1946), 2002During the last two decades the incidence of systemic fungal infections has been rising steadily. The prognosis of infected patients is often poor and the therapeutic strategies are limited. The prophylaxis of systemic fungal infections thus appears worthwhile.
O A, Cornely, A J, Ullmann, M, Karthaus
openaire +1 more source
Inhaled Antifungal Agents for Treatment and Prophylaxis of Bronchopulmonary Invasive Mold Infections
Pharmaceutics, 2022Sandrine Marchand +2 more
exaly
Inhaled Antifungal Agents for the Treatment and Prophylaxis of Pulmonary Mycoses
Current Pharmaceutical Design, 2021Qiuying Liao, Jenny Lam
exaly